Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Grand Finale of AECL Season 7 Concludes in Style – Goa Team Crowned Champions, B Praak Delivers Electrifying Performance Lifestyle
  • Delhi Students to Manage ₹15 Lakh Ad Spend as Part of Digital Marketing Training at NDMIT Press Release
  • Egnoto technologies completes four years of success; Eyes expansion in Australia in the next FY Business
  • Nada Yoga Care Unveils Highly Effective Solution for Curing Rare Diseases and Disabilities Health
  • Transform Your Space: Unveiling the Future of Doors and Windows with Mixx at India Design 2024 Lifestyle
  • Ace Designer Nidhi Yasha Behind Gadar 2’s Stunning and Historically Accurate Costumes Entertainment
  • Upgrade Your Home Security with DeltaHome’s Feature-Packed V50 Smart Lock Business
  • Pooja Ajay kumar Mehta from Ahmedabad grabs two gold medals and creates a world record at the World Powerlifting competition held in Moscow, Russia Press Release

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Himatsingka unveils Himêya, its exclusive Bedding and Bath products brand, with a pan-India presence Business
  • Digital India 2.0: How UPI, AI, and Fintech Are Redefining Business Models Business
  • ALIAUM Boutique Goes Digital: Where Fashion Meets Nature Business
  • Karnataka’s No. 1 Masala Brand, Teju Masala, Provides Tasty & Quality Masala Products Business
  • Rewriting the Rules: AdCounty Media’s Vision for AI Powered Advertising Business
  • MilesWeb Announces the Biggest Independence Day Sale on Web Hosting Business

Recent Posts

  • Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
  • Nidarshana Gowani Leads Tiranga Rally, Celebrating the Spirit of Patriotism and Unity
  • G. S. Grewal Appointed President of Tractor and Mechanization Association (TMA) for 2026–28
  • 350 Collection Boxes Installed Across Surat to Uphold the Dignity of The National Flag
  • Dr. Soumitra Ghosh’s Echoes from Sainik School Revisits Brotherhood, Discipline, and the Journey of Growing Up

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Indowind Energy Limited Announces Rights Issue Opening On December 01, 2025 Business
  • KISNA Diamond and Gold Jewellery Launches its 1st Exclusive Showroom in Jaipur Business
  • UNO MINDA launched its BS VI -compliant Automotive Engine oils for 2 wheelers in the Indian market Business
  • 3 Reasons Why Renting Furniture and Home Appliances is the New Revolution Amongst Millennials? Business
  • Hiten Bhuta’s Leadership Celebrated by Esteemed World Leaders Business
  • An Evening Celebrating the Art of A. A. Almelkar and Akkitham Narayan Lifestyle
  • Policy Execution and Administrative Excellence at FCI: Observations Shared by Sudeep Singh FCI Lifestyle
  • Boisar witnesses property price appreciation of 5% in last 3 years Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme